Management of Infective Endocarditis in Adults
For empiric treatment of infective endocarditis, immediately initiate vancomycin plus gentamicin plus either ampicillin (for native valve) or vancomycin plus gentamicin plus rifampin (for prosthetic valve), then tailor therapy based on culture results and valve type.
Initial Diagnostic Steps Before Antibiotics
- Draw three sets of blood cultures at 30-minute intervals before starting any antibiotics 1
- Obtain echocardiography to detect vegetations, valvular incompetence, and annular abscesses 2
- Immediately consult infectious disease specialists and cardiothoracic surgery as part of a multidisciplinary endocarditis team 3, 4, 5
Empiric Antibiotic Selection Algorithm
The choice of empiric therapy depends on three critical factors 1:
Native Valve Endocarditis (Community-Acquired)
- Ampicillin-sulbactam 12 g/day IV in divided doses PLUS gentamicin 3 mg/kg/day IV 1
- Alternative: Vancomycin 30 mg/kg/day IV in 2 divided doses PLUS gentamicin 3 mg/kg/day for penicillin-allergic patients 1
Prosthetic Valve Endocarditis - Early (<1 year post-surgery)
- Vancomycin 30 mg/kg/day IV PLUS gentamicin 3 mg/kg/day PLUS rifampin 900 mg/day 6
- This covers methicillin-resistant coagulase-negative staphylococci, the most common culprits 6, 5
Prosthetic Valve Endocarditis - Late (>1 year post-surgery)
- Vancomycin PLUS gentamicin with or without third-generation cephalosporin 6
- Consider adding ceftriaxone if HACEK organisms suspected 1
Healthcare-Associated or Nosocomial IE
- Vancomycin PLUS gentamicin PLUS rifampin to cover resistant staphylococci 1
Pathogen-Specific Definitive Therapy
Viridans Group Streptococci (VGS) - Penicillin-Susceptible (MIC ≤0.12 μg/mL)
- Penicillin G 12-18 million units/day IV for 4 weeks (native valve) 1
- Alternative: Ceftriaxone 2 g/day IV for 4 weeks 1
- Prosthetic valve: extend to 6 weeks 7
VGS - Relatively Resistant (MIC 0.12-0.5 μg/mL)
- Penicillin G 24 million units/day IV for 4 weeks PLUS gentamicin 3 mg/kg/day for 2 weeks 1
- Vancomycin 30 mg/kg/day for 4 weeks if penicillin-intolerant (gentamicin NOT needed with vancomycin) 1
VGS - Highly Resistant (MIC ≥0.5 μg/mL)
- Treat as enterococcal endocarditis: ampicillin or penicillin PLUS gentamicin for 4-6 weeks with infectious disease consultation 1
- Ceftriaxone plus gentamicin is a reasonable alternative if ceftriaxone-susceptible 1
Staphylococcus aureus - Methicillin-Susceptible (MSSA)
- Native valve: Nafcillin or oxacillin 12 g/day IV for 6 weeks (or cefazolin as alternative) 8, 6
- Prosthetic valve: Nafcillin PLUS gentamicin (first 2 weeks only) PLUS rifampin 900 mg/day (entire 6 weeks) 8, 6
Staphylococcus aureus - Methicillin-Resistant (MRSA)
- Vancomycin 30 mg/kg/day for 6 weeks 8
- Daptomycin is a reasonable alternative 8
- Prosthetic valve: Add rifampin 900 mg/day for entire 6 weeks PLUS gentamicin for first 2 weeks 8, 6
Enterococcus Species
- Ampicillin 12 g/day IV PLUS gentamicin 3 mg/kg/day for 4-6 weeks 1, 6
- Duration: 4 weeks for native valve, 6 weeks for prosthetic valve 8
HACEK Organisms
- Ceftriaxone 2 g/day IV for 4 weeks (native valve) or 6 weeks (prosthetic valve) 1
- Ampicillin is no longer first-line due to beta-lactamase production 1
Blood Culture-Negative Endocarditis
Specific pathogen-directed therapy 1:
- Bartonella: Doxycycline 100 mg twice daily for 4 weeks PLUS gentamicin 3 mg/kg/day for 2 weeks 1
- Coxiella burnetii (Q fever): Doxycycline 200 mg/day PLUS hydroxychloroquine 200-600 mg/day for >18 months 1
- Brucella: Doxycycline PLUS cotrimoxazole PLUS rifampin for 3-6 months 1
Fungal Endocarditis
- Combined antifungal therapy PLUS mandatory surgical valve replacement 1
- Mortality exceeds 50% even with optimal treatment 1
Critical Aminoglycoside Considerations
Aminoglycoside use has been dramatically reduced over the past 20 years 8:
- Administer once daily dosing (not divided doses) 8
- Limit duration to maximum 2 weeks 8
- Gentamicin is NOT needed when vancomycin is used for streptococcal IE 1
Treatment Duration Summary
- Native valve endocarditis: 4 weeks for most cases 8, 7
- Prosthetic valve endocarditis: 6 weeks 8, 7
- Recent data suggest 4 weeks may be adequate for streptococcal prosthetic valve endocarditis with no increased mortality or relapse 7
- Staphylococcal endocarditis: Always 6 weeks 8
Surgical Indications - Immediate Consultation Required
Obtain cardiothoracic surgery consultation immediately for 3, 2, 4:
- Acute valvular dysfunction causing heart failure
- Prosthetic valve endocarditis (most cases require surgery) 3, 9
- Staphylococcus aureus endocarditis 3
- Fungal endocarditis (surgery mandatory) 1
- Large vegetations ≥10 mm 3
- Myocardial abscess or annular invasion 2
- Persistent bacteremia despite appropriate antibiotics
- Infection with antibiotic-resistant organisms 2
Special Populations and Scenarios
Prosthetic Valve Endocarditis - Conservative Management
- For patients with prohibitive surgical risk, suppressive antibiotic therapy after completing 6 weeks of IV antibiotics is an emerging option 9
- Recent data show 73.9% one-year survival with suppressive therapy in selected patients, with only 5.6% relapse rate 9
- This approach requires careful patient selection by the multidisciplinary team 9
Oral Switch Strategy
- Oral antibiotics are safe after initial IV stabilization in selected patients 8
- Consider for completion of therapy in stable patients without complications 8
Common Pitfalls to Avoid
- Never delay blood cultures waiting for fever - draw immediately when IE suspected 1
- Do not add gentamicin to vancomycin for streptococcal IE - increases toxicity without benefit 1
- Do not use ampicillin monotherapy for HACEK organisms - beta-lactamase production is common 1
- Do not rely on serum bactericidal titers - they do not predict cure or failure 2
- Do not delay surgical consultation - early involvement improves outcomes even if surgery ultimately not performed 3, 4